print PRINT

SCIENCE > Health

Aichi college objects to media reports on its clinical trials of Avigan

  • May 21, 2020
  • , All national papers
  • JMH Summary

All national dailies reported that Fujita Health University in Aichi Prefecture held a press conference on Wednesday regarding its ongoing clinical trials of the flu drug Avigan for COVID-19 treatment. They reportedly said the study will continue since no safety issues were identified by an independent panel that made a preliminary evaluation. The officials dismissed earlier media reports asserting the review panel tentatively concluded that Avigan’s effectiveness was not verified. They underscored that the midterm evaluation was not intended to examine the medicine’s effectiveness in the first place.

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan